Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 259


BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.

Braaten KM, Betensky RA, de Leval L, Okada Y, Hochberg FH, Louis DN, Harris NL, Batchelor TT.

Clin Cancer Res. 2003 Mar;9(3):1063-9.


Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.

Carbone A, Gloghini A, Larocca LM, Capello D, Pierconti F, Canzonieri V, Tirelli U, Dalla-Favera R, Gaidano G.

Blood. 2001 Feb 1;97(3):744-51.


Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.

Colomo L, López-Guillermo A, Perales M, Rives S, Martínez A, Bosch F, Colomer D, Falini B, Montserrat E, Campo E.

Blood. 2003 Jan 1;101(1):78-84.


Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation.

de Leval L, Braaten KM, Ancukiewicz M, Kiggundu E, Delaney T, Mankin HJ, Harris NL.

Am J Surg Pathol. 2003 Sep;27(9):1269-77.


Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.

Ree HJ, Yang WI, Kim CW, Huh J, Lee SS, Cho EY, Ko YH, Charney D.

Hum Pathol. 2001 Sep;32(9):954-62.


Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.

Carbone A, Gloghini A, Cozzi MR, Capello D, Steffan A, Monini P, De Marco L, Gaidano G.

Br J Haematol. 2000 Oct;111(1):247-57.


Bcl-6 predicts improved prognosis in primary central nervous system lymphoma.

Levy O, Deangelis LM, Filippa DA, Panageas KS, Abrey LE.

Cancer. 2008 Jan 1;112(1):151-6.


Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.

Muris JJ, Meijer CJ, Vos W, van Krieken JH, Jiwa NM, Ossenkoppele GJ, Oudejans JJ.

J Pathol. 2006 Apr;208(5):714-23.


Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.

Carbone A, Gloghini A, Gaidano G, Franceschi S, Capello D, Drexler HG, Falini B, Dalla-Favera R.

Blood. 1998 Oct 1;92(7):2220-8.


Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas.

King BE, Chen C, Locker J, Kant J, Okuyama K, Falini B, Swerdlow SH.

Mod Pathol. 2000 Nov;13(11):1219-31.


The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.

Larocca LM, Capello D, Rinelli A, Nori S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Cammilleri-Broet S, Raphael M, Carbone A, Gaidano G.

Blood. 1998 Aug 1;92(3):1011-9.


Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma.

Gascoyne RD, Krajewska M, Krajewski S, Connors JM, Reed JC.

Blood. 1997 Oct 15;90(8):3173-8.


Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.

Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC, Finch CJ, Vilchez RA, McGregor D, Jorgensen JL.

Mod Pathol. 2005 Jun;18(6):806-15. Erratum in: Mod Pathol. 2005 Jun;18(6):873. Medeiros, Leonard J [corrected to Medeiros, L Jeffrey].


Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.

Coupland SE, Foss HD, Hidayat AA, Cockerham GC, Hummel M, Stein H.

J Pathol. 2002 Jul;197(3):333-40.


Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors.

Adams H, Tzankov A, d'Hondt S, Jundt G, Dirnhofer S, Went P.

Hum Pathol. 2008 Sep;39(9):1323-30. doi: 10.1016/j.humpath.2008.01.004.


Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R.

Blood. 2001 Aug 15;98(4):945-51.


Molecular characterization of BCL6 breakpoints in primary diffuse large B-cell lymphomas of the central nervous system identifies GAPD as novel translocation partner.

Montesinos-Rongen M, Akasaka T, Zühlke-Jenisch R, Schaller C, Van Roost D, Wiestler OD, Siebert R, Deckert M.

Brain Pathol. 2003 Oct;13(4):534-8.

Items per page

Supplemental Content

Support Center